tradingkey.logo

NovaBay jumps after $6 million investment, new CEO

ReutersAug 19, 2025 9:52 PM

** Shares of NovaBay Pharmaceuticals NBY.A soar 75% to $1.02 after the bell

** NBY says it has entered into a $6 million securities purchase agreement with private investor David Lazar

** Lazar has also been appointed NBY's CEO, effective immediately

** NBY says it intends to use the proceeds from the investment to pursue a strategic investment and/or an acquisition

** Company also expects to declare a special cash dividend in Q3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI